Bukwang Pharmaceutical Co., Ltd.

Industry

  • Pharmaceuticals
    • Vaccines
    • OTC, Consumer
    • Nutraceuticals
    • Specialty Pharmaceuticals

Other Names/Subsidiaries

  • Anterogen
  • Bukwang Medica
  • Concit Pharma ApS
  • Contera Pharma
  • Dyna Therapeutics
See more in Biomedtracker

Latest on Bukwang Pharmaceutical Co., Ltd.

Scrip

Bukwang Adds To Stacking Mid-Stage Failures In Parkinson's

 
• By Jung Won Shin and Kosh Naran

More mid-stage clinical trial failures are piling up in the Parkinson’s disease space, with the latest disappointment coming from South Korea's Bukwang Pharmaceutical Co., Ltd. , underlining the diff

HBW Insight

Hanmi's Merger Plan Could Spark Power Struggle In South Korea Pharma Sector

 
• By Jung Won Shin

Hanmi Pharm Group has announced a surprise merger with OCI Group in a deal that would place the leading South Korean pharmaceutical firm, with a portfolio including consumer health products, under the

Scrip

Hanmi Announces Merger While Possible Power Struggle Surfaces

 
• By Jung Won Shin

Hanmi Pharm Group has announced a surprise merger with OCI Group in a deal that would place the leading South Korean pharmaceutical group under the wing of the large compatriot energy and chemical ent

Scrip

Deal Watch: Vanda Buys US, Canadian Rights To J&J’s Ponvory

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Vanda To Pay $100m For Rights To MS The